Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer

Costa, Ana, Kieffer, Yann, Scholer-Dahirel, Alix, Pelon, Floriane, Bourachot, Brigitte, Cardon, Melissa, Sirven, Philemon, Magagna, Ilaria, Fuhrmann, Laetitia, Bernard, Charles, Bonneau, Claire, Kondratova, Maria, Kuperstein, Inna, Zinovyev, Andrei, Givel, Anne-Marie, Parrini, Maria-Carla, Soumelis, Vassili, Vincent-Salomon, Anne, Mechta-Grigoriou, Fatima·2018·Cancer Cell

Cited by (1,002)

Items 901–1,000 of 1,002

  1. Evaluation of the role of soluble B7-H3 in association with membrane B7-H3 expression in gastric adenocarcinoma
    Lili Huang, Yan Zhou, Qiuwei Sun, Lei Cao, Xueguang Zhang · 2021 · Cancer Biomarkers
  2. Impact of Immune Cell Heterogeneity on HER2+ Breast Cancer Prognosis and Response to Therapy
    Milena Perrone, Giovanna Talarico, Claudia Chiodoni, Sabina Sangaletti · 2021 · Cancers
  3. Multiplexed In Situ Spatial Protein Profiling in the Pursuit of Precision Immuno-Oncology for Patients with Breast Cancer
    Davide Massa, Anna Tosi, Antonio Rosato, Valentina Guarneri, Maria Vittoria Dieci · 2022 · Cancers
  4. LRRC3B and its promoter hypomethylation status predicts response to anti-PD-1 based immunotherapy
    Linfeng Luo, Sha Fu, Wei Ting Du, Li-na He, Xuanye Zhang, Yixing Wang, Yixin Zhou, Shaodong Hong · 2023 · Frontiers in Immunology
  5. Inhibition of Poly(ADP-ribose) Polymerase Sensitizes [177Lu]Lu-DOTAGA.(SA.FAPi)2-Mediated Radiotherapy in Triple-Negative Breast Cancer
    Guangfa Bao, Huimin Zhou, Sijuan Zou, Lixing Chen, Buchuan Zhang, Ziqiang Wang, Euy Sung Moon, Jun Zhao, Frank Roesch, Xiaohua Zhu · 2023 · Molecular Pharmaceutics
  6. Stiffness-dependent MSC homing and differentiation into CAFs – implications for breast cancer invasion
    Neha Saxena, Soura Chakraborty, Sarbajeet Dutta, Garvit Bhardwaj, Nupur Karnik, Omshree Anil Shetty, Sameer Jadhav, Hamim Zafar, Shamik Sen · 2023 · Journal of Cell Science
  7. Long Non-Coding RNAs as Regulators for Targeting Breast Cancer Stem Cells and Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential
    Fang Yang, Y L Yang, Yuling Qiu, Lin Tang, Li Xie, Xiaoxiang Guan · 2024 · Cancers
  8. Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response
    Yuxuan Xiao, Ziyu Wang, Meng Gu, Panjian Wei, Xiaojue Wang, Weiying Li · 2024 · Clinical and Experimental Medicine
  9. Proteomic Heterogeneity of the Extracellular Matrix Identifies Histologic Subtype-Specific Fibroblast in Gastric Cancer
    Hyun Jin Lee, Yoonjin Kwak, Yun Suk Na, Hye-Jin Kim, Mi Ree Park, Jeong Yeon Jo, Jin Young Kim, Soo‐Jeong Cho, Pilnam Kim · 2024 · Molecular & Cellular Proteomics
  10. Immune response and stromal changes in ductal carcinoma in situ of the breast are subtype dependent
    Marie Colombe Agahozo, Pieter J. Westenend, Mieke Van Bockstal, Tim Hansum, Jenny Giang, Sanne E. Matlung, Carolien H. M. van Deurzen · 2020 · Modern Pathology
  11. Engineering stromal heterogeneity in cancer
    Leon Jia Wei Tang, Ayshath Zaseela, Clarissa Chin Min Toh, Christabella Adine, Abdullah Omer Aydar, Narayanan Gopalakrishna Iyer, Eliza Li Shan Fong · 2021 · Advanced Drug Delivery Reviews
  12. Metabolic pathways fuelling protumourigenic cancer-associated fibroblast functions
    Emily Jane Kay, Sara R. Zanivan · 2021 · Current Opinion in Systems Biology
  13. Effect, Mechanism, and Applications of Coding/Non-coding RNA m6A Modification in Tumor Microenvironment
    Chaohua Si, Chen Chen, Yaxin Guo, Qiaozhen Kang, Zhenqiang Sun · 2021 · Frontiers in Cell and Developmental Biology
  14. High-Dimensional Single-Cell Transcriptomics in Melanoma and Cancer Immunotherapy
    Camelia Y. J. Quek, Xinyu Bai, Georgina Venetia Long, Richard A. Scolyer, James S. Wilmott · 2021 · Genes
  15. Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer
    Melani Luque, Marta Sanz-Álvarez, Andrea Santamaría, Sandra Zazo, Ion Cristóbal, Lorena de la Fuente, Pablo Mínguez, Pîlar Eroles, Ana Rovira, Joan Albanell et al. · 2021 · International Journal of Molecular Sciences
  16. Unsupervised Analysis Based on DCE-MRI Radiomics Features Revealed Three Novel Breast Cancer Subtypes with Distinct Clinical Outcomes and Biological Characteristics
    Wenlong Ming, Fu‐Yu Li, Yanhui Zhu, Yunfei Bai, Wanjun Gu, Yun Liu, Xiaoan Liu, Xiao Song Sun, Hongde Liu · 2022 · Cancers
  17. Single-cell RNA sequencing reveals a dynamic stromal niche within the evolving tumour microenvironment
    Sarah Davidson, Mirjana Efremova, Angela Riedel, Bidesh Mahata, Jhuma Pramanik, Jani Huuhtanen, Gozde Kar, Roser Vento-Tormo, Tzachi Hagai, Xi Xian Chen et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  18. Bioengineering a Patient‐Derived Vascularized Lung Tumor‐on‐Chip Model to Decipher Immunomodulation by the Endothelium
    Christine Lansche, Ségolène Ladaigue, Giacomo Gropplero, Nicolas Zimmermann, Martin Nurmik, Irina Veith, Manh‐Louis Nguyen, Solenn Brosseau, Nicolas Poté, Pierre Mordant et al. · 2025 · Advanced Healthcare Materials
  19. The role of the gut microbiota in shaping the tumor microenvironment and immunotherapy of breast cancer
    Xiaoying Ren, Lixiang Zheng, Ling Huang, Jiangbo Zhao · 2025 · Frontiers in Microbiology
  20. Targeting the tumor microenvironment in triple-negative breast cancer: Biological insights and therapeutic opportunities
    Teresa Maria Martorana, Gabriele Ricciardi, Pietro Tralongo, Vincenzo Fiorentino, Cristina Pizzimenti, Mariausilia Franchina, Maria Adele Marino, Mariacarmela Santarpía, Giovanni Tuccari, Antonio Ieni et al. · 2025 · Pathology - Research and Practice
  21. B7-H3 in the tumor microenvironment: Implications for CAR T cell therapy in pediatric solid tumors
    Lena Jansen, Judith Wienke, Ronja Molkenbur, Claudia Rössig, Ramona Meissner · 2025 · Cancer and Metastasis Reviews
  22. Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axis
    Aoise O’Neill, Norashikin Zakaria, Hannah Egan, Shania M. Corry, Courtney Bull, Niamh A. Leonard, Clodagh O'Meara, Linda Howard, Anastasija Walsh, Eileen Reidy et al. · 2025 · Journal for ImmunoTherapy of Cancer
  23. Similarities between Tumour Immune Response and Chronic Wound Microenvironment: Influence of Mesenchymal Stromal/Stem Cells
    Kimberly Thando Peta, Melvin Anyasi Ambele, Michael Sean Pepper · 2021 · Journal of Immunology Research
  24. Stromal p53 Regulates Breast Cancer Development, the Immune Landscape, and Survival in an Oncogene-Specific Manner
    Jinghai Wu, Xin Liu, Julie W. Reeser, Anthony J. Trimboli, Thierry Pécot, Gina M. Sizemore, Shan K. Naidu, Soledad Fernández, Lianbo Yu, Michael T. Hallett et al. · 2022 · Molecular Cancer Research
  25. The origins, roles and therapies of cancer associated fibroblast in liver cancer
    Natasha Zulaziz, San Jiun Chai, Kue Peng Lim · 2023 · Frontiers in Oncology
  26. Microenvironmental Snail1-induced immunosuppression promotes melanoma growth
    Marta Arumí-Planas, Francisco Javier Rodríguez‐Baena, Francisco Cabello-Torres, Francisco Gracià, Cristina López-Blau, Maria Angela Nieto, Berta L. Sánchez‐Laorden · 2023 · Oncogene
  27. Stereotactic ablative radiotherapy and FAPα-based cancer vaccine suppresses metastatic tumor growth in 4T1 mouse breast cancer
    Meihua Chen, Ling Xiao, Hongyuan Jia, Shubin Wang, Xiao Jiang, Xudan Lei, Qiming Zhai, Jinyi Lang · 2023 · Radiotherapy and Oncology
  28. RETRACTED: An optimal method for melanoma detection from dermoscopy images using reinforcement learning and support vector machine optimized by enhanced fish migration optimization algorithm
    Qianqian Liu, Hiroto Kawashima, Asad Rezaei sofla · 2023 · Heliyon · Retracted
  29. Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer
    Ganggang Wang, Hao Zhang, Xiaowei Shen, Wenzhi Jin, Xiaoliang Wang, Zhijie Zhou · 2023 · Cancer Cell International
  30. Melanoma-associated fibroblasts in tumor-promotion flammation and antitumor immunity: novel mechanisms and potential immunotherapeutic strategies
    Qiujun Zhou, Xiaoliang Jin, Ying Zhao, Yueping Wang, Maocan Tao, Yi Cao, Xiaohu Yin · 2024 · Human Molecular Genetics
  31. High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density
    Sara Corvigno, Josefin Fernebro, Josefin Severin Karlsson, Artur Mezheieusky, Alfonso Martín-Bernabé, Laura Martín de la Fuente, Sofia Westbom-Fremer, Joseph W. Carlson, Christian Klein, Päivi Kannisto et al. · 2025 · Gynecologic Oncology
  32. In-Depth Characterization of Stromal Cells within the Tumor Microenvironment Yields Novel Therapeutic Targets
    Sebastian Gottfried Walter, Sebastian Scheidt, Robert Nißler, Christopher Gaisendrees, Kourosh Zarghooni, Frank Alexander Schildberg · 2021 · Cancers
  33. Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects
    Azam Bozorgi, Maryam Bozorgi, Mozafar Khazaei · 2022 · Cellular Oncology
  34. EIF4A3 stabilizes the expression of lncRNA AGAP2‐AS1 to activate cancer‐associated fibroblasts via MyD88 / NF ‐κb signaling
    Qingqing Xu, Tingting Zhao, Honghao Han, Jiahao Fan, Weiping Xie · 2022 · Thoracic Cancer
  35. Modelling metastasis in zebrafish unveils regulatory interactions of cancer-associated fibroblasts with circulating tumour cells
    Pablo Hurtado, Inés Martínez-Peña, Sabrina Yepes-Rodríguez, Miguel Bascoy-Otero, Carmen Abuín, Cristóbal Fernández-Santiago, Laura E. Sanchez, Rafael López‐López, Roberto Piñeiro · 2023 · Frontiers in Cell and Developmental Biology
  36. Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?
    Shuaiqingying Guo, Jing Yuan, Xiaolin Meng, Xue Feng, Ding Ma, Yingyan Han, Kezhen Li · 2023 · International Immunopharmacology
  37. Modeling chemical effects on breast cancer: the importance of the microenvironment in vitro
    Molly M. Morgan, Linda A. Schuler, Jordan C. Ciciliano, Brian P. Johnson, Elaine T. Alarid, David J. Beebe · 2020 · Integrative Biology
  38. Molecular mechanism of PARP inhibitor resistance
    Yi Huang, Simin Chen, Nan Yao, Shikai Lin, Junyi Zhang, Chengrui Xu, Chenxuan Wu, Guo Chen, Danyang Zhou · 2024 · Oncoscience
  39. Laser-activated nanoparticles rewire tumor microenvironment enhancing PD-1 blockade and T cell response in cholangiocarcinoma
    Mirko Minini, Giulio Avveduto, Sonia Becharef, Marie Meunier--Thaens, Bouchra Lekbaby, María Pérez-Lanzón, Alice Machado, Thomas Guilbert, Julie Lesieur, Gilles Renault et al. · 2025 · Hepatology
  40. Cancer Cell B7-H3 Expression Is More Prevalent in the Pancreato-Biliary Subtype of Ampullary Cancer Than in Pancreatic Cancer
    Emma E. Geerdes, Kostandinos Sideras, Mohammad Hosein Aziz, Casper H.J. van Eijck, Marco J. Bruno, Dave Sprengers, Patrick P.C. Boor, Jaap Kwekkeboom · 2021 · Frontiers in Oncology
  41. Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer
    Limei Wang, Haitang Yang, Patrick Dorn, Sabina Berezowska, Fabian Blank, Carlos Wotzkow, Thomas M. Marti, Ren‐Wang Peng, Nathalie E. Harrer, Wolfgang Sommergruber et al. · 2021 · EBioMedicine
  42. Cancer‑associated fibroblasts as cellular vehicles in endometrial cancer cell migration
    Yap Voon, Intan Sofia Omar, Ming–Heng Wu, Nur Akmarina B.M. Said, Ivy Chung · 2021 · Oncology Letters
  43. Propensity for Early Metastatic Spread in Breast Cancer: Role of Tumor Vascularization Features and Tumor Immune Infiltrate
    Mario Rosario D'Andrea, Vittore Cereda, Luigi Coppola, Guido Giordano, Andrea Remo, Elena De Santis · 2021 · Cancers
  44. Bibliometric analysis of worldwide research trends on breast cancer about inflammation
    Guangran Meng, Huilin Xu, Sheng‐Tao Yang, Feixiang Chen, Wenyuan Wang, Furong Hu, Gang Zheng, Yixin Guo · 2023 · Frontiers in Oncology
  45. Hybrid computational modeling highlights reverse warburg effect in breast cancer-associated fibroblasts
    Sahar Aghakhani, Sacha E Silva-Saffar, Sylvain Soliman, Anna Niarakis · 2023 · Computational and Structural Biotechnology Journal
  46. Metabolic-suppressed cancer-associated fibroblasts limit the immune environment and survival in colorectal cancer with liver metastasis
    Chenghao Wu, Shaobo Yu, Yanzhong Wang, Yuzhen Gao, Xinyou Xie, Jun Zhang · 2023 · Frontiers in Pharmacology
  47. Stress in the metastatic journey – the role of cell communication and clustering in breast cancer progression and treatment resistance
    Eloïse M. Grasset, Sophie Barillé‐Nion, Philippe Paul Juin · 2024 · Disease Models & Mechanisms
  48. M2-Type Macrophages and Cancer-Associated Fibroblasts Combine to Promote Colorectal Cancer Liver Metastases
    Yunpeng Feng, Shifeng Qiao, Jie Chen, Xin Wen, Yanlei Chen, Xiaoyu Song, Jiaxin Xu, X. Qiao, Jing Yang, Shenshen Zhang et al. · 2024 · OncoTargets and Therapy
  49. Single-cell analysis reveals one cancer-associated fibroblasts subtype linked to metastasis in breast cancer: MXRA5 as a potential novel marker for prognosis
    Huifang Deng · 2024 · American Journal of Cancer Research
  50. Spatial transcriptomics analysis identifies a tumor-promoting function of the meningeal stroma in melanoma leptomeningeal disease
    Hasan Alhaddad, Oscar E. Ospina, Mariam Lotfy Khaled, Yuan Ren, Ethan J. Vallebuona, Mohammad Baraa Boozo, Peter Forsyth, Yolanda Piña, Robert J.B. Macaulay, Vincent Law et al. · 2024 · Cell Reports Medicine
  51. Biomimetic Hydrogel‐Mediated Mechano‐Immunometabolic Therapy for Inhibition of ccRCC Recurrence After Surgery
    Yunze Dong, Jun Luo, Mingliang Pei, Shuai Liu, Yuchen Gao, Hongmin Zhou, Yimingniyizi Nueraihemaiti, Xiangcheng Zhan, Tiancheng Xie, Xudong Yao et al. · 2024 · Advanced Science
  52. Comprehensive macro and micro views on immune cells in ischemic heart disease
    Yongjian Zhao, Mingyue Tan, Yunfei Yin, Jun Zhang, Yiyi Song, Hang Li, Yan Lin, Yifeng Jin, Ziyue Wu, Tianke Yang et al. · 2024 · Cell Proliferation
  53. Engineered bacterial membrane vesicle as safe and efficient nano-heaters to reprogram tumor microenvironment for enhanced immunotherapy
    Kunguo Liu, Shiyu Du, Jiawei Yang, Juanjuan Li, Shijie Wang, Zhibin Zhang, Wen Luo, Chao Chen, Jingjing Yang, Xin Han · 2024 · Journal of Controlled Release
  54. Targeting G Protein–Coupled Receptors in Immuno-Oncological Therapies
    John Stagg, Jorge Silvio Gutkind · 2024 · The Annual Review of Pharmacology and Toxicology
  55. Advancing tumor vaccines: Overcoming TME challenges, delivery strategies, and biomaterial-based vaccine for enhanced immunotherapy
    Qingsong Zeng, Shibo Zhang, Ning Leng, Yingying Xing · 2024 · Critical Reviews in Oncology/Hematology
  56. Cancer-associated fibroblasts as a potential novel liquid biopsy marker in cancer patients
    Franziska D. Weber, Kim-Lea Reese, Klaus Pantel, Daniel J. Smit · 2025 · Journal of Experimental & Clinical Cancer Research
  57. CXCL12 is expressed by skeletal muscle cells in tongue oral squamous cell carcinoma
    Akira Yorozu, Shohei Sekiguchi, Akira Takasawa, Fumika Okazaki, Takeshi Niinuma, Hiroshi Kitajima, Eiichiro Yamamoto, Masahiro Kai, Mutsumi Toyota, Yui Hatanaka et al. · 2022 · Cancer Medicine
  58. Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology
    Ralf Huss, Johannes Raffler, Bruno Märkl · 2023 · Cancer Reports
  59. Analysis of stromal PDGFR-β and α-SMA expression and their clinical relevance in brain metastases of breast cancer patients
    Md Rashedunnabi Akanda, Eun‐Jung Ahn, Yeong Jin Kim, S M Abdus Salam, Myung‐Giun Noh, Tae‐Kyu Lee, Sung Sun Kim, Kyung‐Hwa Lee, Kyung‐Sub Moon · 2023 · BMC Cancer
  60. Mendelian Randomization Validates the Immune Landscape Mediated by Aggrephagy in Esophageal Squamous Cell Carcinoma Patients from the Perspectives of Multi-omics
    Haiyang Yu, Gao Si, Fu-Chun Si · 2024 · Journal of Cancer
  61. Immune escape mechanisms in head and neck squamous cell carcinoma and implication for new immunotherapy approach
    Marco Carlo Merlano, Nerina Denaro, Ornella Garrone · 2020 · Current Opinion in Oncology
  62. l-malic acid: A multifunctional metabolite at the crossroads of redox signaling, microbial symbiosis, and therapeutic innovation
    Jiandong Lu, Zhisheng Zhang, Siqiao Wu, Chun‐qi Gao · 2025 · Archives of Biochemistry and Biophysics
  63. Insights into the Mechanisms of Immune‐Checkpoint Inhibitors Gained from Spatiotemporal Dynamics of the Tumor Microenvironment
    Yuanyuan Zhang, Zhihua Liu · 2025 · Advanced Science
  64. Interleukin-1β and cancer immune response
    Cédric Rébé, François Ghiringhelli · 2025 · Seminars in Immunology
  65. Heterogeneity and plasticity of cancer-associated fibroblasts
    Sneha Pramod, Hagar Lavon, Ruth Scherz‐Shouval, Mara H. Sherman · 2026 · Nature Cancer
  66. Exosomes: Small Vesicles with Important Roles in the Development, Metastasis and Treatment of Breast Cancer
    Ling’ao Meng, Kedong Song, Shenglong Li, Yue Kang · 2022 · Membranes
  67. Forces exerted and transduced by cancer‐associated fibroblasts during cancer progression
    Madison E. Bates, Sarah Libring, Cynthia A. Reinhart‐King · 2023 · Biology of the Cell
  68. Updates on radiotherapy-immunotherapy combinations: Proceedings of 6 th annual ImmunoRad conference
    Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos‐Hoff, Nina Bhardwaj, Charleen Chan Wah Hak, Alba Fiorentino, Chandan Guha, Mónica L. Guzmán, Kevin Joseph Harrington, Fernanda Gabriela Herrera et al. · 2023 · OncoImmunology
  69. Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer
    Shefali Thakur, Syed Aleem Haider, Rachael Natrajan · 2023 · The Journal of Pathology
  70. Improving cancer immunotherapy by preventing cancer stem cell and immune cell linking in the tumor microenvironment
    Dongyu Li, Lei Wang, Bo Jiang, Yuchen Jing, Xuan Li · 2023 · Biomedicine & Pharmacotherapy
  71. MMP-11 expression in early luminal breast cancer: associations with clinical, MRI, pathological characteristics, and disease-free survival
    Sébastien Molière, Massimo Lodi, Suzanne Leblanc, Anne Gressel, Carole Mathelin, Fabien Alpy, Marie‐Pierre Chenard, Catherine Tomasetto · 2024 · BMC Cancer
  72. Exploring the association of POSTN+ cancer-associated fibroblasts with triple-negative breast cancer
    Shuangyan Lin, Miaoni Zhou, Liying Cheng, Zhifeng Shuai, Mingyuan Zhao, Ruixia Jie, Qun Wan, Fang Peng, Shiping Ding · 2024 · International Journal of Biological Macromolecules
  73. Exploring the multifaceted role of direct interaction between cancer cells and fibroblasts in cancer progression
    Nilu Dhungel, Ana‐Maria Dragoi · 2024 · Frontiers in Molecular Biosciences
  74. Evaluation of Targeted Alpha Therapy Using [211At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models
    Kaori Abe, Tadashi Watabe, Kazuko Kaneda‐Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga, Sadahiro Naka, Kazuhiro Ooe, Atsushi Toyoshima, Frederik Lars Giesel, Takeshi Usui et al. · 2024 · International Journal of Molecular Sciences
  75. Unveiling the Tumor Microenvironment Through Fibroblast Activation Protein Targeting in Diagnostic Nuclear Medicine: A Didactic Review on Biological Rationales and Key Imaging Agents
    Juliette Fouillet, Jade Torchio, Léa Rubira, Cyril Fersing · 2024 · Biology
  76. Crosstalk between miRNAs and signaling pathways in the development of drug resistance in breast cancer
    Reza Amiri, Poorya Najjari Nabi, Ahmad Fazilat, Fatemeh Roshani, Alireza Nouhi Kararoudi, Mohsen Hemmati-Dinarvand, Mohammad Valilo · 2024 · Hormone Molecular Biology and Clinical Investigation
  77. Unraveling the tumor microenvironment of esophageal squamous cell carcinoma through single-cell sequencing: A comprehensive review
    Lingyu Qi, Jiaxin Wang, Songyuan Hou, Siying Liu, Qian Zhang, Shengtao Zhu, Si Liu, Shutian Zhang · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  78. Cancer-associated fibroblasts in ovarian cancer: research progress
    Yuance Xu, Danting Sun, Junqi He, Qin Yao · 2025 · Frontiers in Oncology
  79. Research advances of secretory proteins in malignant tumors
    Na Zhang, Jia‐Jie Hao, Yan Cai, Ming‐Rong Wang · 2021 · Chinese Journal of Cancer Research
  80. Cancer-associated fibroblasts in gynecological malignancies: are they really allies of the enemy?
    Julio César Villegas‐Pineda, Adrián Ramírez-de-Arellano, Lesly Jazmín Bueno-Urquiza, Mélida del Rosario Lizarazo-Taborda, Ana Laura Pereira-Suárez · 2023 · Frontiers in Oncology
  81. Novel CAF-identifiers via transcriptomic and protein level analysis in HNSC patients
    Nehanjali Dwivedi, Nidhi Shukla, K. M. Prathima, Manjula Das, Sujan Kumar Dhar · 2023 · Scientific Reports
  82. Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia
    Lena Jassowicz, Claudia Dürr, Selcen Öztürk, Manuela Zucknick, Axel Benner, Verena Kalter, Sibylle Ohl, Viola Close, Patrick Wuchter, Stephan Stilgenbauer et al. · 2019 · Cancers
  83. In Vitro and Ex Vivo Models – The Tumor Microenvironment in a Flask
    Catarina Pinto, Marta F Estrada, Catarina Brito · 2020 · Advances in experimental medicine and biology
  84. Skin Cancer Detection Using Kernel Fuzzy C‐Means and Improved Neural Network Optimization Algorithm
    Huaping Jia, Zhao Junlong, Ali Mohammad norouzzadeh Gil Molk · 2021 · Computational Intelligence and Neuroscience
  85. Inhibition of RAC1 activity in cancer associated fibroblasts favours breast tumour development through IL-1β upregulation
    Angélica Martínez‐López, Ana García‐Casas, Paloma Bragado, Akira Orimo, Eduardo Castañeda-Saucedo, Sonia Castillo‐Lluva · 2021 · Cancer Letters
  86. Polyclonal Rabbit Anti-Cancer-Associated Fibroblasts Globulins Induce Cancer Cells Apoptosis and Inhibit Tumor Growth
    Li, Xiuying, Huang, Fengchang, Xu, Xiaoyu, Hu, Shuenqin · 2018 · International Journal of Biological Sciences
  87. Hypoxic microenvironment in cancer: role in metabolic reprogramming
    Sureka, Niti, Maheshwari, Rashi, Agravat, Amit, Singhal, Shweta, Zaman, Shamsuz, Rishi, Bhavika, Siraj, Fouzia, Zaheer, Sufian, Misra, Aroonima · 2026 · Frontiers in Oncology
  88. Identification and validation of an m6A-related gene signature to predict prognosis and evaluate immune features of breast cancer
    Wenhao Li, Xiaolong Wang, Chen Li, Tong Chen, Xianyong Zhou, Zheng Li, Qifeng Yang · 2022 · Human Cell
  89. Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma
    Fei‐Qi Xu, Meng-Meng Dong, Zhifei Wang, Lidong Cao · 2023 · Frontiers in Immunology
  90. Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis
    Н. М. Тодосенко, И. А. Хлусов, Kristina Alekseevna Yurova, О. Г. Хазиахматова, Larisa Sergeevna Litvinova · 2023 · International Journal of Molecular Sciences
  91. The immune regulatory function of B7-H3 in malignancy: spotlight on the IFN-STAT1 axis and regulation of tumor-associated macrophages
    Robin Park, James Yu, Moazzam Shahzad, Sunggon Lee, Jong Dae Ji · 2024 · Immunologic Research
  92. The long and winding road to biomarkers for immunotherapy: a retrospective analysis of samples from patients with triple-negative breast cancer treated with pembrolizumab
    Laurence Buisseret, Yacine Barèche, David Venet, E. Girard, Andrea Gombos, Patrick Emonts, Samira Majjaj, Ghizlane Rouas, Matteo Serra, Véronique Debien et al. · 2024 · ESMO Open
  93. FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review)
    Julia Maria Sołek, Marcin Braun, Rafał Sądej, Hanna Romańska · 2024 · International Journal of Oncology
  94. Bridging the tumor microenvironment: the pivotal role of cancer-associated fibroblasts in tumor cachexia development
    Guoming Chen, Bonan Chen, Yilin Wu, Hao Nie, Zilan Zhong, Shuyang Yang, Rui Qin, Wei Kang, Cheng Zhang, Ning Wang et al. · 2025 · Molecular Cancer
  95. Antifibrotic Therapy Augments the Antitumor Effects of Vesicular Stomatitis Virus Via Reprogramming Tumor Microenvironment
    Yanwei Chen, Shichuan Hu, Yongheng Shu, Zhongbing Qi, Bin Zhang, Yueting Kuang, Jinhu Ma, Ping Cheng · 2021 · Human Gene Therapy
  96. Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer
    Giovanni Vitale, Michele Caraglia, Volker Jung, Jörn Kamradt, Davide Gentilini, Maria Teresa Di Martino, Alessandra Dicitore, Marianna Abate, Pierosandro Tagliaferri, Annalisa Itro et al. · 2022 · Cancers
  97. A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
    Huili Wu, Xiao Li Zhao, Tingting Zhu, Di Rong, Ying Wang, Diya Leng, Daming Wu · 2022 · Frontiers in Genetics
  98. Biological heterogeneity of primary cancer-associated fibroblasts determines the breast cancer microenvironment.
    Marika Musielak, Oliwia Piwócka, Katarzyna Ida Kulcenty, Karolina Ampuła, Beata Adamczyk, Igor Piotrowski, Magdalena Fundowicz, Marta Kruszyna‐Mochalska, Wiktoria Maria Suchorska, Julian Malicki · 2022 · PubMed Central
  99. Integrated single-cell and bulk RNA sequencing analyses reveal a prognostic signature of cancer-associated fibroblasts in head and neck squamous cell carcinoma
    Yichen Yang, Ben Ma, Litao Han, Weibo Xu, Xiaoxue Du, Wenjun Wei, Tian Liao, Qinghai Ji, Ning Qu, Yu Wang · 2022 · Frontiers in Genetics
  100. SALL4 ‐related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features
    Angélique Vienot, Franck Monnien, Caroline Truntzer, Virginie Mougey, Adeline Bouard, Jean‐René Pallandre, Chloé Molimard, Romain Loyon, Kamal Asgarov, Gerlinde Avérous et al. · 2023 · Molecular Oncology